Duloxetine (a moderate inhibitor of CYP2D6) may inhibit the metabolism of propafenone (a substrate for CYP2D6), increasing the risk of propafenone adverse effects. The manufacturer advises caution.
(18)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.